Using the shRNA system to suppress SLCO4A1-AS1 resulted in the inhibition of the IKK/NF-κB pathway, which led to reduced migration, invasion, and proliferation in lung cancer cells A549 and H1299. Here, NFKB1 is linked to lung carcinoma.